Skip to main content
Premium Trial:

Request an Annual Quote

Imaging Research, Genicon Collaborate to Market Microarray, Informatic Tool Kit

NEW YORK, Oct. 12 - Imaging Research has signed a software licensing, promotion, and distribution agreement with Genicon Sciences that will marry Imaging’s ArrayVision analysis software with Genicon's RLS signal-detection technology, the companies announced on Friday.

Through the collaboration, Genicon’s Resonance Light Scattering technology, which the company says may be applied to many molecular-assay platforms, and Imaging Research's ArrayVision, which is used to analyze gene expression and protein arrays, will be combined “to provide a complete research and analysis tool kit.”

Terms of the deal call for Genicon, of San Diego, to promote and commercialize Imaging’s ArrayVision product with its own RLS technology. The agreement also allows for the ArrayVision software to be customized for additional RLS applications, and grants Genicon the option to promote ArrayStat, Imaging Research's other informatics product.

Financial details of the agreement were not disclosed.

"We are delighted that Genicon has selected Imaging Research products as a key component of their signal detection, measurement and analysis process," David Burns, chief operating officer of St. Catharines, Ontario-based Imaging Research, said in a statement. "The high-quality RLS array images, when analyzed by ArrayVision software, yield more meaningful data and longer-lasting results."

Patrick Mallon, CEO of Genicon Sciences, added that combining the two products “will give researchers open access to a validated system for conducting accurate microarray experimentation.”

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.